Vancouver, British Columbia, October 14, 2025 — TheNewswire - Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) is pleased to announce that it has closed the previously announced debt settlement agreements (the “Settlements Agreements”) to settle outstanding debts totaling USD$1,386,391 and CAD$9,432,107 owed to certain arm’s length creditors and a non-arm length creditor (the “Creditors”) of the Company for unpaid invoices, management fees, and unpaid convertible debent ...